Home -> Law Blog Directory -> Personal Injury Law Blogs -> Philadelphia Personal Injury Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Philadelphia Personal Injury LawyerNinth Case of PML With Biogen's Tysabri
By Jamie Sheller
Recently, Biogen Idec Inc. reported a ninth case of the brain infection progressive multifocal leukoencephalopathy (PML) connected to the drug Tysabri. PML is a potentially deadly infection. Tysabri is a multiple sclerosis drug by Biogen. In 2005, Tysabri was pulled from the market due to reports of PML, but in July 2006 it was reintroduced with restrictions. The recently announced PML case brings the number of cases to nine since the reintroduction in 2006. About 24,900 patients have received at least one year of Biogen's Tysabri treatment since 2006.
If you have taken Tysabri and developed PML, contact Sheller, P.C. to discuss whether you have a legal claim. The lawyers at Sheller have many years of experience successfully representing people who have been injured by defective drugs.
Originally posted at InjuryBoard by Jamie ShellerFull post as published by Philadelphia Personal Injury Lawyer on June 25, 2009 (boomark / email).
Gleevec
Possible Case of Kidney Damage Reported
Hampton Inn
Third Case of Legionnaires' Disease Linked to McHenry Hampton Inn Hot Tub
18-Wheeler Accident Case Settled for $600,000
18-Wheeler Accident Case Settled for $600,000
Jury Awards $29M in Elder Abuse Case
Jury Awards $29M in Elder Abuse Case
Female Sales Reps Win Gender Case Against Novartis
Female Sales Reps Win Gender Case Against Novartis

FDA working to update Tysabri label after two patients diagnosed with serious brain infection
April 2009 Update: Another Tysabri Patient Develops Serious Brain Infection PML
Prescription Drugs - Liver Damage - FDA Warning - Tysabri
Liver injury warnings added to Biogen Idecs Tysabri labels








